a borderline significant trendp = 0.061
In muscle-invasive (T2–T4) tumours, there was a borderline significant trend towards a reduced 5-year OS for tumours with low RBM3 expression ( p = 0.061, Fig. 4c ).
In muscle-invasive (T2–T4) tumours, there was a borderline significant trend towards a reduced 5-year OS for tumours with low RBM3 expression ( p = 0.061, Fig. 4c ).
In T1 tumours, PODXL was significantly associated with reduced survival in univariable analysis (HR = 2.83; 95% CI 1.04–7.72) and borderline significant in multivariable analysis (HR = 2.60; 95% CI 0.91–7.39).